US health organizations have suggested states pause administration of the Johnson & Johnson coronavirus vaccine after reports of rare and serious blood clots developed in six women. More than 6.8m doses have been administered nationally.
The concerns reflect those of drug agencies in Europe and Australia over the AstraZeneca vaccine. That immunization isn't authorized within the US, and there have been no critical safety concerns raised about the two other vaccines that make up the majority of US supply, from Pfizer-BioNTech and Moderna.
Johnson & Johnson’s vaccine is additionally under investigation by the European Medicines Agency, which is examining four cases of clotting. All six women were between the ages of 18 and 48. One lady died, and a lady in Nebraska is hospitalized in critical care, according to the New York Times.
The pause in administration of the Johnson & Johnson vaccine is certain to be a blow to the American immunization campaign. Which was set to administer hundreds of thousands of easy-to-administer doses given by the company.
Source: The Guardian
Apply Now. Hodler Capital Group will help you access business financing. We will show you how to build your business credit. We can also help you build a business website. To start growing your business contact us now.